"Red flag" evaluation yield in irritable bowel syndrome
- PMID: 22720303
"Red flag" evaluation yield in irritable bowel syndrome
Abstract
Background: The diagnosis of irritable bowel syndrome (IBS) is based on clinical criteria. Further diagnostic testing is advised for certain "red flag" alarm or warning signs.
Aim: This investigation was designed to examine the yield of testing for "red flags".
Methods: Consecutive patients who were prospectively evaluated and met the ROME III criteria for IBS were reviewed for "red flags" which included: 1) rectal bleeding, 2) iron-deficiency anemia (IDA), 3) weight loss, 4) family history of colon cancer, 5) fever, and 6) age of onset after age 50. The evaluations were reviewed for type of testing and findings. Subjects with nocturnal symptoms and fecal soiling, although not traditional warning signs, were also reviewed.
Results: There were 200 patients who met the IBS criteria; 139 (70%) had a "red flag" alarm symptom or sign. Diarrhea predominant-IBS (D-IBS) was seen in 105, constipation predominant-IBS (C-IBS) in 57, alternating, mixed, or pain predominant-IBS in 38. There were 30 men and 170 women. Testing was not often performed in this setting and, when done, the yield was low with few clinically significant diagnostic findings.
Conclusion: There was a high prevalence of "red flag" symptoms or signs in the prospectively evaluated IBS cohort, but a low frequency of diagnostic testing directed at the investigation of these symptoms or signs. Further systematic study may show that the yield for testing in IBS is low even when "red flags" prompt diagnostic testing.
Similar articles
-
Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x. J Gastroenterol Hepatol. 2012. PMID: 21929652
-
When to conduct testing in patients with suspected irritable bowel syndrome.Rev Gastroenterol Disord. 2003;3 Suppl 3:S18-24. Rev Gastroenterol Disord. 2003. PMID: 14502113 Review.
-
Irritable bowel syndrome: a population based study.J Gastrointestin Liver Dis. 2009 Dec;18(4):413-8. J Gastrointestin Liver Dis. 2009. PMID: 20076812
-
Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61. doi: 10.1111/j.1365-2036.2007.03422.x. Aliment Pharmacol Ther. 2007. PMID: 17767480
-
A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.Int J Clin Pract. 2006 Jan;60(1):57-63. doi: 10.1111/j.1368-5031.2005.00744.x. Int J Clin Pract. 2006. PMID: 16409429 Review.
Cited by
-
A Rome III survey of functional dyspepsia among the ethnic Malays in a primary care setting.BMC Gastroenterol. 2013 May 14;13:84. doi: 10.1186/1471-230X-13-84. BMC Gastroenterol. 2013. PMID: 23672671 Free PMC article.
-
Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?Cureus. 2022 May 19;14(5):e25137. doi: 10.7759/cureus.25137. eCollection 2022 May. Cureus. 2022. PMID: 35747043 Free PMC article.
-
Review of the role of abdominal imaging in irritable bowel syndrome.World J Radiol. 2018 Nov 28;10(11):143-149. doi: 10.4329/wjr.v10.i11.143. World J Radiol. 2018. PMID: 30568748 Free PMC article. Review.
-
Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study.World J Clin Cases. 2022 Jan 14;10(2):563-575. doi: 10.12998/wjcc.v10.i2.563. World J Clin Cases. 2022. PMID: 35097082 Free PMC article.
-
Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.J Neurogastroenterol Motil. 2018 Apr 30;24(2):197-215. doi: 10.5056/jnm17145. J Neurogastroenterol Motil. 2018. PMID: 29605976 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous